The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gonadotropin-releasing Hormone Antagonists Market Research Report 2025
Synopsis
Gonadotropin-releasing hormone antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, LHRH antagonist, and luteinizing hormone-releasing hormone antagonist.
The global Gonadotropin-releasing Hormone Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gonadotropin-releasing Hormone Antagonists include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Antagonists.
Report Scope
The Gonadotropin-releasing Hormone Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gonadotropin-releasing Hormone Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Segment by Type
Peptides
Small Molecules
Segment by Application
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gonadotropin-releasing hormone antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, LHRH antagonist, and luteinizing hormone-releasing hormone antagonist.
The global Gonadotropin-releasing Hormone Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gonadotropin-releasing Hormone Antagonists include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Antagonists.
Report Scope
The Gonadotropin-releasing Hormone Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gonadotropin-releasing Hormone Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Segment by Type
Peptides
Small Molecules
Segment by Application
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gonadotropin-releasing Hormone Antagonists Market Overview
1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Antagonists
1.2 Gonadotropin-releasing Hormone Antagonists Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 Peptides
1.2.3 Small Molecules
1.3 Gonadotropin-releasing Hormone Antagonists Segment by Application
1.3.1 Global Gonadotropin-releasing Hormone Antagonists Market Value by Application: (2024-2030)
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Global Gonadotropin-releasing Hormone Antagonists Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Antagonists Revenue 2019-2030
1.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales 2019-2030
1.4.3 Global Gonadotropin-releasing Hormone Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gonadotropin-releasing Hormone Antagonists Market Competition by Manufacturers
2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gonadotropin-releasing Hormone Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Gonadotropin-releasing Hormone Antagonists Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Type & Application
2.7 Gonadotropin-releasing Hormone Antagonists Market Competitive Situation and Trends
2.7.1 Gonadotropin-releasing Hormone Antagonists Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue
2.7.3 Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario by Region
3.1 Global Gonadotropin-releasing Hormone Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gonadotropin-releasing Hormone Antagonists Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2019-2030
3.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2019-2024
3.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2025-2030
3.3 Global Gonadotropin-releasing Hormone Antagonists Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2019-2030
3.3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2019-2024
3.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2025-2030
3.4 North America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2030)
3.4.3 North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2030)
3.5.3 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2030)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2030)
3.7.3 Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2019-2030)
4.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2019-2024)
4.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2025-2030)
4.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2019-2030)
4.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2019-2030)
4.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2019-2024)
4.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2025-2030)
4.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2019-2030)
5.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2019-2024)
5.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2025-2030)
5.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2019-2030)
5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2019-2030)
5.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2019-2024)
5.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2025-2030)
5.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Astellas
6.3.1 Astellas Corporation Information
6.3.2 Astellas Description and Business Overview
6.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.3.5 Astellas Recent Developments/Updates
6.4 Kissei
6.4.1 Kissei Corporation Information
6.4.2 Kissei Description and Business Overview
6.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.4.5 Kissei Recent Developments/Updates
6.5 Veru Inc
6.5.1 Veru Inc Corporation Information
6.5.2 Veru Inc Description and Business Overview
6.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.5.5 Veru Inc Recent Developments/Updates
6.6 Myovant Sciences
6.6.1 Myovant Sciences Corporation Information
6.6.2 Myovant Sciences Description and Business Overview
6.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.6.5 Myovant Sciences Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Ferring Pharmaceuticals
6.8.1 Ferring Pharmaceuticals Corporation Information
6.8.2 Ferring Pharmaceuticals Description and Business Overview
6.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.8.5 Ferring Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine Co
6.9.1 Jiangsu Hengrui Medicine Co Corporation Information
6.9.2 Jiangsu Hengrui Medicine Co Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadotropin-releasing Hormone Antagonists Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Antagonists Production Mode & Process
7.4 Gonadotropin-releasing Hormone Antagonists Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Antagonists Sales Channels
7.4.2 Gonadotropin-releasing Hormone Antagonists Distributors
7.5 Gonadotropin-releasing Hormone Antagonists Customers
8 Gonadotropin-releasing Hormone Antagonists Market Dynamics
8.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
8.2 Gonadotropin-releasing Hormone Antagonists Market Drivers
8.3 Gonadotropin-releasing Hormone Antagonists Market Challenges
8.4 Gonadotropin-releasing Hormone Antagonists Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gonadotropin-releasing Hormone Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gonadotropin-releasing Hormone Antagonists Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gonadotropin-releasing Hormone Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gonadotropin-releasing Hormone Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gonadotropin-releasing Hormone Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2019-2024) & (K Units)
Table 18. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2025-2030) & (K Units)
Table 20. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2024) & (K Units)
Table 27. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2025-2030) & (K Units)
Table 28. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Type (2019-2024)
Table 51. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Type (2025-2030)
Table 52. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2019-2024)
Table 59. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2025-2030)
Table 60. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Application (2019-2024)
Table 61. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Application (2025-2030)
Table 62. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2019-2024)
Table 69. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Gonadotropin-releasing Hormone Antagonists Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Takeda Gonadotropin-releasing Hormone Antagonists Product
Table 79. Takeda Recent Developments/Updates
Table 80. Astellas Corporation Information
Table 81. Astellas Description and Business Overview
Table 82. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Astellas Gonadotropin-releasing Hormone Antagonists Product
Table 84. Astellas Recent Developments/Updates
Table 85. Kissei Corporation Information
Table 86. Kissei Description and Business Overview
Table 87. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Kissei Gonadotropin-releasing Hormone Antagonists Product
Table 89. Kissei Recent Developments/Updates
Table 90. Veru Inc Corporation Information
Table 91. Veru Inc Description and Business Overview
Table 92. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Veru Inc Gonadotropin-releasing Hormone Antagonists Product
Table 94. Veru Inc Recent Developments/Updates
Table 95. Myovant Sciences Corporation Information
Table 96. Myovant Sciences Description and Business Overview
Table 97. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product
Table 99. Myovant Sciences Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Ferring Pharmaceuticals Corporation Information
Table 106. Ferring Pharmaceuticals Description and Business Overview
Table 107. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product
Table 109. Ferring Pharmaceuticals Recent Developments/Updates
Table 110. Jiangsu Hengrui Medicine Co Corporation Information
Table 111. Jiangsu Hengrui Medicine Co Description and Business Overview
Table 112. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product
Table 114. Jiangsu Hengrui Medicine Co Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gonadotropin-releasing Hormone Antagonists Distributors List
Table 118. Gonadotropin-releasing Hormone Antagonists Customers List
Table 119. Gonadotropin-releasing Hormone Antagonists Market Trends
Table 120. Gonadotropin-releasing Hormone Antagonists Market Drivers
Table 121. Gonadotropin-releasing Hormone Antagonists Market Challenges
Table 122. Gonadotropin-releasing Hormone Antagonists Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gonadotropin-releasing Hormone Antagonists
Figure 2. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gonadotropin-releasing Hormone Antagonists Market Share by Type in 2023 & 2030
Figure 4. Peptides Product Picture
Figure 5. Small Molecules Product Picture
Figure 6. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gonadotropin-releasing Hormone Antagonists Market Share by Application in 2023 & 2030
Figure 8. Prostate Cancer
Figure 9. Endometriosis
Figure 10. Uterine Fibroids
Figure 11. Female Infertility
Figure 12. Others
Figure 13. Global Gonadotropin-releasing Hormone Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gonadotropin-releasing Hormone Antagonists Market Size (2019-2030) & (US$ Million)
Figure 15. Global Gonadotropin-releasing Hormone Antagonists Sales (2019-2030) & (K Units)
Figure 16. Global Gonadotropin-releasing Hormone Antagonists Average Price (USD/Unit) & (2019-2030)
Figure 17. Gonadotropin-releasing Hormone Antagonists Report Years Considered
Figure 18. Gonadotropin-releasing Hormone Antagonists Sales Share by Manufacturers in 2023
Figure 19. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Gonadotropin-releasing Hormone Antagonists Players: Market Share by Revenue in 2023
Figure 21. Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Gonadotropin-releasing Hormone Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2019-2030)
Figure 24. North America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2019-2030)
Figure 25. United States Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2019-2030)
Figure 28. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2019-2030)
Figure 29. Germany Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2019-2030)
Figure 36. China Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2019-2030)
Figure 46. Latin America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Gonadotropin-releasing Hormone Antagonists by Type (2019-2030)
Figure 56. Global Revenue Market Share of Gonadotropin-releasing Hormone Antagonists by Type (2019-2030)
Figure 57. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Gonadotropin-releasing Hormone Antagonists by Application (2019-2030)
Figure 59. Global Revenue Market Share of Gonadotropin-releasing Hormone Antagonists by Application (2019-2030)
Figure 60. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2019-2030)
Figure 61. Gonadotropin-releasing Hormone Antagonists Value Chain
Figure 62. Gonadotropin-releasing Hormone Antagonists Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
